Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹3,025Cr
Rev Gr TTM
Revenue Growth TTM
-6.90%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

NOCIL
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -15.1 | -22.1 | -9.8 | 4.6 | -9.2 | -6.2 | 3.4 | -6.6 | -4.7 | -9.7 | -11.6 | -0.7 |
| 343 | 341 | 306 | 292 | 312 | 331 | 325 | 294 | 305 | 306 | 298 | 289 |
Operating Profit Operating ProfitCr |
| 12.7 | 14.1 | 12.9 | 14.3 | 12.5 | 11.0 | 10.4 | 7.5 | 10.1 | 9.1 | 7.0 | 8.5 |
Other Income Other IncomeCr | 3 | 5 | 5 | 6 | 25 | 9 | 8 | 9 | 6 | 7 | 10 | 1 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 14 | 13 | 13 | 13 | 13 | 13 | 13 | 14 | 13 | 14 | 14 | 14 |
| 39 | 47 | 37 | 41 | 56 | 37 | 32 | 19 | 26 | 23 | 19 | 13 |
| 10 | 13 | 9 | 11 | 14 | 10 | -10 | 6 | 5 | 6 | 6 | 4 |
|
Growth YoY PAT Growth YoY% | -58.9 | -48.4 | -24.0 | 61.1 | 46.7 | -21.1 | 55.1 | -57.0 | -50.0 | -36.2 | -71.2 | -28.3 |
| 7.2 | 8.7 | 7.7 | 8.8 | 11.7 | 7.3 | 11.6 | 4.0 | 6.1 | 5.1 | 3.8 | 2.9 |
| 1.7 | 2.1 | 1.6 | 1.8 | 2.5 | 1.6 | 2.5 | 0.8 | 1.3 | 1.0 | 0.7 | 0.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -0.5 | 3.8 | 30.4 | 7.8 | -18.9 | 9.3 | 69.9 | 2.9 | -10.6 | -3.6 | -5.8 |
| 606 | 576 | 583 | 702 | 750 | 668 | 794 | 1,285 | 1,364 | 1,250 | 1,255 | 1,198 |
Operating Profit Operating ProfitCr |
| 15.8 | 19.5 | 21.4 | 27.4 | 28.1 | 21.1 | 14.2 | 18.2 | 15.6 | 13.5 | 9.9 | 8.7 |
Other Income Other IncomeCr | 4 | 4 | 10 | 15 | 10 | 9 | 15 | 4 | 6 | 39 | 32 | 23 |
Interest Expense Interest ExpenseCr | 17 | 9 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 |
Depreciation DepreciationCr | 15 | 15 | 20 | 24 | 24 | 34 | 37 | 48 | 56 | 53 | 54 | 55 |
| 86 | 119 | 147 | 255 | 278 | 152 | 107 | 241 | 202 | 180 | 114 | 81 |
| 29 | 41 | 50 | 85 | 93 | 22 | 19 | 65 | 53 | 47 | 11 | 22 |
|
| | 37.1 | 24.1 | 75.0 | 8.8 | -29.3 | -32.3 | 99.2 | -15.3 | -10.8 | -22.7 | -42.2 |
| 7.9 | 10.9 | 13.1 | 17.6 | 17.7 | 15.4 | 9.6 | 11.2 | 9.2 | 9.2 | 7.4 | 4.5 |
| 3.5 | 4.9 | 6.0 | 10.3 | 11.2 | 7.9 | 5.3 | 10.6 | 8.9 | 8.0 | 6.2 | 3.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 161 | 161 | 164 | 164 | 165 | 166 | 166 | 167 | 167 | 167 | 167 | 167 |
| 254 | 309 | 750 | 882 | 998 | 1,020 | 1,119 | 1,279 | 1,385 | 1,532 | 1,595 | 1,604 |
Current Liabilities Current LiabilitiesCr | 233 | 130 | 119 | 164 | 155 | 141 | 210 | 259 | 171 | 166 | 160 | 169 |
Non Current Liabilities Non Current LiabilitiesCr | 107 | 82 | 128 | 120 | 124 | 116 | 120 | 126 | 134 | 151 | 134 | 132 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 380 | 314 | 417 | 673 | 580 | 426 | 623 | 844 | 881 | 976 | 934 | 853 |
Non Current Assets Non Current AssetsCr | 375 | 368 | 744 | 658 | 863 | 1,017 | 992 | 987 | 976 | 1,039 | 1,123 | 1,219 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 30 | 170 | 142 | 102 | 164 | 179 | 94 | -30 | 282 | 201 | 26 |
Investing Cash Flow Investing Cash FlowCr | -5 | -12 | -10 | -142 | -101 | -106 | -62 | 31 | -217 | -77 | -37 |
Financing Cash Flow Financing Cash FlowCr | -33 | -151 | -31 | -43 | -50 | -101 | 0 | -34 | -54 | -55 | -50 |
|
Free Cash Flow Free Cash FlowCr | 30 | 170 | 129 | 55 | -73 | 0 | 67 | -64 | 253 | 185 | -95 |
| 52.6 | 217.7 | 145.8 | 60.2 | 88.8 | 137.3 | 105.8 | -17.2 | 189.1 | 151.1 | 24.9 |
CFO To EBITDA CFO To EBITDA% | 26.5 | 122.2 | 88.9 | 38.6 | 56.0 | 100.7 | 71.5 | -10.6 | 111.6 | 103.0 | 18.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 605 | 741 | 1,535 | 3,145 | 2,434 | 1,090 | 2,902 | 4,155 | 3,438 | 4,154 | 2,921 |
Price To Earnings Price To Earnings | 11.2 | 10.0 | 15.8 | 18.5 | 13.2 | 8.3 | 32.8 | 23.6 | 23.1 | 31.2 | 28.4 |
Price To Sales Price To Sales | 0.8 | 1.0 | 2.1 | 3.3 | 2.3 | 1.3 | 3.1 | 2.6 | 2.1 | 2.9 | 2.1 |
Price To Book Price To Book | 1.5 | 1.6 | 1.7 | 3.0 | 2.1 | 0.9 | 2.3 | 2.9 | 2.2 | 2.5 | 1.7 |
| 6.4 | 5.3 | 8.9 | 11.7 | 8.2 | 6.1 | 21.6 | 14.5 | 13.4 | 20.9 | 21.1 |
Profitability Ratios Profitability Ratios |
| 46.0 | 49.7 | 51.5 | 54.5 | 55.2 | 54.2 | 45.4 | 45.3 | 45.1 | 43.6 | 42.7 |
| 15.8 | 19.5 | 21.4 | 27.4 | 28.1 | 21.1 | 14.2 | 18.2 | 15.6 | 13.5 | 9.9 |
| 7.9 | 10.9 | 13.1 | 17.6 | 17.7 | 15.4 | 9.6 | 11.2 | 9.2 | 9.2 | 7.4 |
| 19.0 | 26.4 | 16.2 | 24.4 | 23.9 | 12.9 | 8.4 | 16.7 | 13.0 | 10.6 | 6.5 |
| 13.8 | 16.6 | 10.6 | 16.2 | 15.9 | 11.0 | 6.9 | 12.2 | 9.6 | 7.8 | 5.8 |
| 7.6 | 11.5 | 8.4 | 12.8 | 12.8 | 9.1 | 5.5 | 9.6 | 8.0 | 6.6 | 5.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
NOCIL Limited, part of the Arvind Mafatlal Group, is India’s largest manufacturer of rubber chemicals with over four decades of industry experience. The company is globally recognized for its technical excellence, sustainable practices, and reliable supply chain, positioning itself as a key non-Chinese supplier in an industry dominated by China, which accounts for over 80% of global production. NOCIL serves more than 40 countries across the tire, automotive, industrial rubber goods, and footwear sectors, leveraging a robust export strategy and strategic “China +1” supply chain diversification trends.
---
### **Manufacturing & Operations**
NOCIL operates two advanced manufacturing facilities:
- **Navi Mumbai Plant**: Established in 1976, this facility uses state-of-the-art technology and automated control systems to produce a wide range of rubber chemicals meeting international standards.
- **Dahej Plant (Gujarat)**: Commissioned in March 2013, this fully automated, in-house developed, and environmentally compliant facility benefits from strategic proximity to India’s petrochemical cluster and major ports (Dahej and Hazira), ensuring logistical efficiency.
The Dahej plant features:
- Continuous process automation and indigenous technology.
- Modern effluent treatment systems aligned with 3Rs (Reduce, Reuse, Recycle).
- ISO 9001, ISO 14001, OHSAS 18001, IATF 16949, NABL, and Responsible Care certifications.
---
### **Strategic Capex & Capacity Expansion**
NOCIL has committed to a **demand-led, modular expansion program**:
- Announced capital expenditure of **₹250 crores (Oct 2025)** for the Dahej facility to expand **TDQ antioxidant** production capacity and strengthen the **Rubber Chemicals (RC)** business.
- Previously invested **₹470 crores (Jul 2021)** and planned a **₹450 crore (Aug 2020)** phased expansion, with significant capacity already commissioned.
- De-bottlenecking initiatives are ongoing to meet short- and medium-term demand, with long-term capacity planning aligned with global market shifts.
The company remains **debt-free**, funding expansions through internal accruals.
---
### **Product Portfolio & Applications**
NOCIL offers a **comprehensive range of over 20 rubber chemical products**, serving as a **one-stop supplier**:
- **Accelerators** (e.g., PILCURE®): Reduce vulcanization time and temperature, improving energy efficiency.
- **Anti-degradants & Antioxidants** (e.g., PILNOX®, PILFLEX®): Prevent oxygen- and heat-induced degradation, extending rubber product life.
- **Pre- & Post-Vulcanization Inhibitors** (e.g., PILGARD®): Enhance process control and product stability.
- **Latex-based and specialty formulations**: Serve niche applications in medical gloves, industrial belts, hoses, footwear, and molded components.
The portfolio supports both **tire** (primary market) and **non-tire rubber applications**, reducing reliance on cyclical tire demand.
---
### **Market Positioning & Competitive Advantage**
NOCIL is strategically positioned as a **preferred non-Chinese supplier** in the rubber chemicals sector. Key competitive strengths include:
- **"Supplier of Choice" status** with major global tire manufacturers, including for their Indian operations.
- High **customer stickiness** due to 6–18 month plant-specific approval cycles and long-term contracts.
- **Self-sufficiency in key chemical intermediates**, enhancing supply security and cost efficiency.
- **Backward integration** and proprietary technology—absent in most Indian competitors.
China’s dominance (80% share) and supply chain vulnerabilities (due to environmental issues, trade wars, and pandemic disruptions) have accelerated the **“China +1”** strategy, favoring NOCIL’s expansion.
---
### **R&D, Innovation & Sustainability**
NOCIL integrates **R&D with manufacturing** to drive sustainable innovation:
- **R&D Centre recognized by DSIR**, equipped with advanced labs, pilot plants, and analytical systems.
- Focus areas: **Green Chemistry, Industry 4.0, carbon footprint reduction, and atom economy**.
- Pipeline of next-generation, eco-friendly products aligned with global ESG demands.
- Technical support team (MTS) provides end-to-end customer solutions in rubber compounding and application engineering.
Sustainability is embedded via:
- Energy-efficient processes.
- Waste minimization and closed-loop effluent treatment.
- Compliance with **Responsible Care®** standards.
---
### **Financial & Performance Highlights**
- **FY15 to FY24 Revenue**: Grew from ₹719 crores to ₹1,445 crores (**2x increase**).
- **EBITDA**: Rose from ₹112 crores in FY15 to ₹195 crores in FY24 (**1.7x growth**).
- **Domestic Turnover (Jul 2024)**: ₹965 crores.
- **Export Revenue (Jul 2024)**: ₹473 crores.
- Maintained consistent **dividend payouts for over six years**, reflecting financial stability.
Despite raw material cost volatility and competition, NOCIL has demonstrated resilience and outperformed the industry, growing **74% in volume over the past decade** vs. 20% global rubber consumption growth.
---
### **Challenges & Mitigation**
- **Aggressive Pricing Competition**: From China, Korea, and Europe. NOCIL counters with differentiated products, technical support, and reliability.
- **China Dumping**: NOCIL has filed **anti-dumping petitions** with India’s DGTR on key products; outcomes expected soon may level the playing field.
- **Entry Barriers**: Long customer approval processes provide a sustainable moat against new entrants.